- Home
- LPTX vs EFOI Comparison
LPTX vs EFOI Comparison
Compare LPTX & EFOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- EFOI
- Stock Information
- Founded
- LPTX 2011
- EFOI 1985
- Country
- LPTX United States
- EFOI United States
- Employees
- LPTX N/A
- EFOI N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- EFOI Building Products
- Sector
- LPTX Health Care
- EFOI Consumer Discretionary
- Exchange
- LPTX Nasdaq
- EFOI Nasdaq
- Market Cap
- LPTX 14.7M
- EFOI 12.6M
- IPO Year
- LPTX N/A
- EFOI 1994
- Fundamental
- Price
- LPTX $0.35
- EFOI $2.29
- Analyst Decision
- LPTX Hold
- EFOI
- Analyst Count
- LPTX 1
- EFOI 0
- Target Price
- LPTX N/A
- EFOI N/A
- AVG Volume (30 Days)
- LPTX 3.3M
- EFOI 29.2K
- Earning Date
- LPTX 08-11-2025
- EFOI 08-12-2025
- Dividend Yield
- LPTX N/A
- EFOI N/A
- EPS Growth
- LPTX N/A
- EFOI N/A
- EPS
- LPTX N/A
- EFOI N/A
- Revenue
- LPTX N/A
- EFOI $4,643,000.00
- Revenue This Year
- LPTX N/A
- EFOI N/A
- Revenue Next Year
- LPTX N/A
- EFOI N/A
- P/E Ratio
- LPTX N/A
- EFOI N/A
- Revenue Growth
- LPTX N/A
- EFOI N/A
- 52 Week Low
- LPTX $0.22
- EFOI $1.14
- 52 Week High
- LPTX $4.79
- EFOI $2.95
- Technical
- Relative Strength Index (RSI)
- LPTX 52.39
- EFOI 52.69
- Support Level
- LPTX $0.32
- EFOI $2.22
- Resistance Level
- LPTX $0.36
- EFOI $2.92
- Average True Range (ATR)
- LPTX 0.03
- EFOI 0.18
- MACD
- LPTX 0.01
- EFOI -0.02
- Stochastic Oscillator
- LPTX 86.94
- EFOI 13.70
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About EFOI Energy Focus Inc.
Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.